Revitalizes Weak Organs Organic Renovation & Revitalizing
Cellorgane Multi-Complex 2G
INDICATIONS AND DOSAGE:
Indications:
Cellorgane Multicomplex for Women: Ovarian Failure, Menstrual Irregularities, Obesity (Hormonal Causes), Psychophysical Asthenia, Heart Failure, Depression, Memory Problems, Chronic Intoxication, Geriatric Treatments, Pernicious Anemia, Liver Failure.
In general, injectable Cellorgane Multicomplex 2G is administered in a dose of 2 ml daily for 5 days, until the 10-ml vial is finished.
However, it is always up to the doctor's discretion to decide which dosage and which therapeutic plan he will use, according to each specific case, set of symptoms and pathology.
The clinical experiences yielded support the combined use thereof with other medications, since the coadjutant action prove the preventative efficacy of Cellorgane Multicomplex 2G.
INDICATIONS:
By specialisation, dose, frequency and administration of treatment.
In Internal Medicine, Gynaecology and Regenerative Medicine:
As a Revitalising and Regenerative Treatment:
The initial recommended dosage is as follows: once the lyofilised mix has been combined with the cellular protoplasm fluid, inject one partial dose of two (2) ml from the 10-ml vial of Cellorgane Multicomplex 2G for Men or Women, according to the sex of the patient, for a total of 20 consecutive injections, once daily, for a period of 20 days. It is recommended to suspend treatment for 10 consecutive days and to resume it by injecting 2 ml every other day, for a total of 20 injections (10 vials) of injectable Cellorgane Multicomplex 2G over a period of 20 days.
It is recommended to combine these treatments with Cellorgane Multicomplex 2G Oral, indicating one tablet during the day and one tablet in the evening (1 b.i.d.) before meals for 60 days. Treatment may be repeated according to the patient's condition and results. Generally, this treatment is recommended every six (6) months. Patient should undergo a medical evaluation once the first 2 months of treatment have been completed.
Results: During the first few weeks of treatment, an improvement of all organ values will be noted, and the patient's vitality and energy will increase.
Preventative Revitalising Treatment:
The initial recommended dosage is as follows: once the lyofilised mix has been combined with the cellular protoplasm fluid, inject one partial dose of two (2) ml from the 10-ml vial of Cellorgane Multicomplex 2G for Men or Women, according to the sex of the patient, every other day, for a total of 10 injections over 20 days. In addition, it is recommended to take 2 tablets of Cellorgane Multicomplex 2G Oral daily (1 b.i.d.) in the morning and the evening, before meals, for 3 consecutive days. Patient should undergo a medical evaluation once the first 2 months of treatment have been completed.
Results: During the first few weeks of treatment, an improvement of all organ values will be noted, and the patient's vitality and energy will increase.
Treatment for specific diseases, such as:
Loss of Libido. The initial recommended dose is as follows: once the lyofilised mix has been combined with the cellular protoplasm fluid, inject one partial dose of two (2) ml from the 10-ml vial of Cellorgane Multicomplex 2G for Men or Women, according to the sex of the patient, every other day, for a total of 20 injections over 2 months. Treatment should be combined with 2 tablets of Cellorgane Multicomplex 2G Oral daily (1 b.i.d.) in the morning and the evening, before meals, for up to 6 months. Patient should undergo a medical evaluation once the first 2 months of treatment have been completed.
Results: Once the first stages of the treatment have elapsed, the patient should experience an improvement in his/her symptoms and increased libido.
Stress: The initial recommended dose is as follows: once the lyofilised mix has been combined with the cellular protoplasm fluid, inject one partial dose of two (2) ml from the 10-ml vial of Cellorgane Multicomplex 2G for Men or Women, according to the sex of the patient, for a total of 20 injections over 20 consecutive days. Treatment should be combined with 2 tablets of Cellorgane Multicomplex 2G Oral daily (1 b.i.d.) in the morning and the evening, before meals, (60 tablets a month) for 3 months. Patient should undergo a medical evaluation once the first 2 months of treatment have been completed.
Results: Once the first stages of treatment have been completed, the patient should experience an improvement in his/her symptoms.
Asthenia: The initial recommended dose is as follows: once the lyofilised mix has been combined with the cellular protoplasm fluid, inject one partial dose of two (2) ml from the 10-ml vial of Cellorgane Multicomplex 2G for Men or Women, according to the sex of the patient. Treatment should be combined with two (2) tablets of Cellorgane Multicomplex 2G Oral daily (1 b.i.d.) in the morning and the evening, before meals, (60 tablets a month) for 6 months. Patient should undergo a medical evaluation once the first 2 months of treatment have been completed.
Results: During the first few weeks of treatment, an improvement of all organ values will be noted, and the patient's vitality and energy will increase.
In Internal Medicine:
Liver deficiency, cirrhosis of the liver, arthritis, mental exhaustion, rheumatism, pernicious anemia, rickets and growth disorders:
The initial recommended dose is as follows: once the lyofilised mix has been combined with the cellular protoplasm fluid, inject one partial dose of two (2) ml from the 10-ml vial of Cellorgane Multicomplex 2G for Men or Women, according to the sex of the patient, every other day, for a total of 60 injections. At the same time, the following dose of Cellorgane Multicomplex 2G Oral should be indicated: one in the morning and one in the evening (1 b.i.d), before meals, for six (6) consecutive months.
In Gynaecology:
Premature Menopause and Climacterium: The initial recommended dose is as follows: once the lyofilised mix has been combined with the cellular protoplasm fluid, inject one partial dose of two (2) ml from the 10-ml vial of Cellorgane Multicomplex 2G for Women every other day, for a total of 10 injections over 20 days. In both cases, this treatment should be accompanied by one (1) dose of Cellorgane Multicomplex 2G Oral, one in the morning and one in the evening (1 b.i.d.) before meals, for 60 days. Patient should undergo clinical evaluations once the first 2 months of treatment have been completed. Treatment may be repeated with no contraindication or risk to the patient. Generally, this treatment is recommended with satisfactory results every six (6) months in patients over 45 years of age and in other cases of premature menopause.
Results: Once the first stages of treatment have been completed, the patient should notice a marked improvement in her symptoms.
Polycystic Ovary Disease. The initial recommended dose is as follows: once the lyofilised mix has been combined with the cellular protoplasm fluid, inject one partial dose of two (2) ml from the 10-ml vial of Cellorgane Multicomplex 2G for Women daily, for a total of 20 injections over 20 days. In both cases, this treatment should be accompanied by one (1) dose of Cellorgane Multicomplex 2G Oral, one in the morning and one in the evening (1 b.i.d.) before meals, for 90 days.
Once two (2) months of treatment have been completed, patient should undergo an ultrasound evaluation to determine whether the clinical symptoms have diminished or disappeared and, depending on these results, whether to continue the treatment, at the doctor's discretion, for two (2) more months.
 |
||
More Information |
||
| » Cellorgane Multicomplex 2G » Clinical Information and Pharmacology » Indications » Analysis |
» Contraindications » Side Effects » Clinical Study » Mechanisms of Action |
» Pharmacokinetics » Bibliography » Exclusive For Doctors |